March 24 (Reuters) - Quest Pharmatech Inc QPT.V :
* ONCOQUEST ANNOUNCES PUBLICATION OF TWO REPORTS RELATED TO OREGOVOMAB PHASE 2 CLINICAL TRIAL, THE COMPANY'S LEAD INVESTIGATIONAL DRUG IN FRONTLINE OVARIAN CANCER
* QUEST PHARMATECH INC - CURRENTLY PLANNING TO LAUNCH A PHASE 3 TRIAL IN Q2 2020.